Alamar Biosciences Files Initial Ownership Statement
Ticker: ALMR · Form: 3 · Filed: Apr 17, 2026
Sentiment: neutral
Topics: insider-filing, ownership, sec-form-3
TL;DR
Alamar Biosciences just filed a Form 3 - initial ownership report. Keep an eye on insider moves.
AI Summary
On April 16, 2026, Alamar Biosciences, Inc. filed a Form 3, an initial statement of beneficial ownership of securities. This filing indicates the initial reporting of ownership for securities related to the company. The filing was made by Justin J. McAnear, who is associated with 10X Genomics, Inc.
Why It Matters
This Form 3 filing marks the initial public disclosure of beneficial ownership of securities for Alamar Biosciences, Inc., providing transparency for investors.
Risk Assessment
Risk Level: low — A Form 3 filing is a standard initial disclosure and does not inherently represent a change in risk for the company.
Key Players & Entities
- Alamar Biosciences, Inc. (company) — Issuer of securities
- Justin J. McAnear (person) — Reporting person associated with 10X Genomics, Inc.
- 10X Genomics, Inc. (company) — Company associated with the reporting person
- April 16, 2026 (date) — Filing date of the Form 3
FAQ
What type of SEC filing is this?
This is a Form 3, an initial statement of beneficial ownership of securities.
Who is the issuer of the securities?
The issuer is Alamar Biosciences, Inc.
When was the filing made?
The filing date was April 16, 2026.
Who is listed as a reporting person or associated with the filing?
Justin J. McAnear is listed as a reporting person, associated with 10X Genomics, Inc.
What is the purpose of a Form 3 filing?
A Form 3 is used to report the initial beneficial ownership of securities by an insider or a large shareholder.
Filing Details
This Initial Statement of Beneficial Ownership (Form 3) was filed with the SEC on April 17, 2026 by Justin J. McAnear regarding Alamar Biosciences, Inc. (ALMR). Form 3 filings establish the initial ownership position of company insiders when they first assume their role.